SKI Market

A+| A| A-|

Indian Indices

Sensex

75,477.25 -25.60
( -0.03%)

Global Indices

Nasdaq

46,970.79 391.31
(0.84%)

Dow Jones

6,721.52 68.33
(1.03%)

Hang Seng

53,729.78 -89.83
(-0.17%)

Nikkei 225

10,338.98 77.83
(0.76%)

Forex

USD-INR

92.32 0.03
(0.03%)

EUR-INR

105.40 -1.04
(-0.98%)

GBP-INR

122.05 -1.31
(-1.06%)

JPY-INR

0.58 0.00
(-0.37%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78690

INE0MRE01011

67.8370031

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFINIUM

36.83

311.66

EPS(TTM)

Face Value()

Div & Yield %

5.43

Back

aditya birla sun life crisil liquid overnight etf

KCL Infra Projects reports standalone net loss of Rs 0.33 crore in the September 2025 quarter

Nov 16,2025

Net loss of KCL Infra Projects reported to Rs 0.33 crore in the quarter ended September 2025 as against net profit of Rs 0.07 crore during the previous quarter ended September 2024. Sales reported to Rs 1.02 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1.02	0	0
OPM %	-64.71	0	-
PBDT	-0.44	0.11	PL
PBT	-0.45	0.09	PL
NP	-0.33	0.07	PL

75,477.25 -25.60 ( -0.03%)

46,970.79 391.31 (0.84%)

6,721.52 68.33 (1.03%)

53,729.78 -89.83 (-0.17%)

10,338.98 77.83 (0.76%)

92.32 0.03 (0.03%)

105.40 -1.04 (-0.98%)

122.05 -1.31 (-1.06%)

0.58 0.00 (-0.37%)